Skip to main content
. 2022 Jan 1;13(1):76–87. doi: 10.7150/jca.59777

Table 3.

Metabolites different between OSCC and HC

ID Name Formula Molecular RT (min) VIP P FC AUC FDR
1 Uridine C9H12N2O6 244.06227 1.00 1.028 1.02E-10 0.718 0.882 8.53E-10
2 Chiro-inositol C6H12O6 180.05553 1.01 1.283 0.027 1.093 0.742 0.049
3 Lactate C3H6O3 90.02322 1.01 1.158 0.026 1.089 0.632 0.047
4 Taurine C2H7NO3S 125.00639 1.01 1.906 3.35E-13 0.662 0.906 4.07E-12
5 Glutamate C5H9NO4 147.04501 1.02 1.907 1.96E-13 0.650 0.912 2.52E-12
6 Uric acid C5H4N4O3 168.02017 1.02 2.858 8.53E-10 0.882 0.620 0.021
7 Acetylcarnitine C9H17NO4 204.12285 1.02 1.662 1.23E-05 0.682 0.774 2.9E-03
8 Citric acid C6H8O7 192.01939 1.27 3.304 1.37E-08 0.616 0.872 8.67E-07
9 Phenylalanine C9H11NO2 165.08591 2.10 2.277 3.10E-05 0.784 0.785 0.003
10 Octanoylcarnitine C15H29NO4 287.21661 5.50 1.003 1.52E-06 0.671 0.801 7.67E-06
11 Glycocholic acid C26H43NO6 465.30295 6.21 1.333 9.60E-05 2.588 0.779 3.27 E-04
12 Decanoylcarnitine C17H33NO4 315.24823 6.25 1.033 9.68E-06 0.604 0.812 3.54E-05
13 Cholic acid C24H40O5 408.28140 6.80 2.060 0.010 4.751 0.779 0.021
14 Glycoursodeoxycholic acid C26H43NO5 449.30765 6.93 2.325 0.004 1.763 0.726 0.009
15 N-Succinyl-2,6-diaminoheptanedioate C11H18N2O7 289.10617 7.20 1.788 5.92E-12 0.485 0.899 6.01E-11
16 16-HETE C20H32O3 320.25098 8.03 1.016 8.12E-13 0.393 0.810 7.50E-06
17 LysoPC(16:0) C24H50NO7P 495.33951 8.68 12.443 1.81E-20 0.565 0.970 1.19E-17
18 LysoPC(18:1) C26H52NO7P 521.35571 8.87 11.090 4.10E-19 0.663 0.950 6.38E-19
19 9,10-Epoxyoctadecenoic acid C18H32O3 296.22832 9.22 3.145 0.002 0.660 0.706 0.008
20 Arachidonic acid C20H32O2 304.23315 10.03 5.301 6.77E-09 0.635 0.845 4.45E-08
21 Oleamide C18H35NO 281.27872 10.14 2.071 3.50E-23 0.092 0.502 4.01E-05

OSCC, oral squamous cell carcinoma; HC, healthy control; FC, fold change; RT, retention time; VIP, variable importance in projection; FC, fold change; AUC, area under curve; FDR, false discovery rate, calculation based on Benjamini and Hochberg.